FindTrial
Sign In

Device validation study for detecting likely presnce of COVID-19

Development, validation, pilot deployment of an ultra scalable technology SWAASA AI, as an auxiliary to COVID 19 rapid test.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/09/036489
Enrollment
200
Registered
2021-09-14
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

Cellular and Molecular Platforms
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Male or female patients, 18 years of age and over. Patients able to read, understand and sign the Informed Consent Form. Newly diagnosed COVID 19 Patients.

Exclusion criteria

Exclusion criteria: Patients less than 18 years of age Pregnant females. Asymptomatic patients attending isolation ward for COVID testing Patients on ventilators support

Design outcomes

Primary

MeasureTime frame
Validation of the SWAASA AI Platform in detecting likely presence of COVID-19 by comparing with the final clinical diagnosis based on test results of a standard reference test or tests.Timepoint: 5 months—

Secondary

MeasureTime frame
Evaluate the effectiveness of Swaasa AI platform in detecting COVID-19 in a primary health care settingTimepoint: 2 months—

Countries

India

Contacts

Public ContactNarayana Rao Sripada

Andhra Medical College

padmalathamdgen@gmail.com9246620072

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026